RT @PNHP: Medicare Advantage: Sharply increased out-of-pocket charges for chemotherapy, pushing "expensive" cancer patients out of their pl…
RT @PNHP: Medicare Advantage: Sharply increased out-of-pocket charges for chemotherapy, pushing "expensive" cancer patients out of their pl…
RT @PNHP: Medicare Advantage: Sharply increased out-of-pocket charges for chemotherapy, pushing "expensive" cancer patients out of their pl…
RT @PNHP: Medicare Advantage: Sharply increased out-of-pocket charges for chemotherapy, pushing "expensive" cancer patients out of their pl…
RT @PNHP: Medicare Advantage: Sharply increased out-of-pocket charges for chemotherapy, pushing "expensive" cancer patients out of their pl…
RT @PNHP: Medicare Advantage: Sharply increased out-of-pocket charges for chemotherapy, pushing "expensive" cancer patients out of their pl…
RT @PNHP: Medicare Advantage: Sharply increased out-of-pocket charges for chemotherapy, pushing "expensive" cancer patients out of their pl…
RT @PNHP: Medicare Advantage: Sharply increased out-of-pocket charges for chemotherapy, pushing "expensive" cancer patients out of their pl…
RT @PNHP: Medicare Advantage: Sharply increased out-of-pocket charges for chemotherapy, pushing "expensive" cancer patients out of their pl…
RT @PNHP: Medicare Advantage: Sharply increased out-of-pocket charges for chemotherapy, pushing "expensive" cancer patients out of their pl…
RT @PNHP: Medicare Advantage: Sharply increased out-of-pocket charges for chemotherapy, pushing "expensive" cancer patients out of their pl…
RT @PNHP: Medicare Advantage: Sharply increased out-of-pocket charges for chemotherapy, pushing "expensive" cancer patients out of their pl…
RT @PNHP: Medicare Advantage: Sharply increased out-of-pocket charges for chemotherapy, pushing "expensive" cancer patients out of their pl…
RT @PNHP: Medicare Advantage: Sharply increased out-of-pocket charges for chemotherapy, pushing "expensive" cancer patients out of their pl…
RT @PNHP: Medicare Advantage: Sharply increased out-of-pocket charges for chemotherapy, pushing "expensive" cancer patients out of their pl…
RT @PNHP: Medicare Advantage: Sharply increased out-of-pocket charges for chemotherapy, pushing "expensive" cancer patients out of their pl…
Medicare Advantage: Sharply increased out-of-pocket charges for chemotherapy, pushing "expensive" cancer patients out of their plans. #MedicareForAll: Reduces copays, coinsurance, and deductibles to ZERO. Source: https://t.co/msDzDHxMWv via @JournalGIM
"...fewer plans offering full coverage or copayments for Part B #chemotherapy...percentage of beneficiaries with no cost-sharing...declined from 30% in 2008 to 9% in 2018...1% of beneficiaries had copayments in 2018, down from 24% in 2008" @LauraKeohane @V
RT @JournalGIM: Over the past decade, an increasing share of #Medicare Advantage members had 20% coinsurance for chemotherapy administered…
RT @JournalGIM: Over the past decade, an increasing share of #Medicare Advantage members had 20% coinsurance for chemotherapy administered…
Over the past decade, an increasing share of #Medicare Advantage members had 20% coinsurance for chemotherapy administered in a clinical office as fewer plans offered fixed copayments or full coverage. @VUHealthPol https://t.co/PTp6ATgskl https://t.co/QSNn
RT @VUHealthPol: Regulations have impacted out-of-pocket costs for #Medicare Advantage patients on chemotherapy. Read more in a new piece b…
RT @tricia_neuman: New study worth reading: out-of-pocket costs have increased for #MedicareAdvantage enrollees who take cancer drugs cover…
Regulations have impacted out-of-pocket costs for #Medicare Advantage patients on chemotherapy. Read more in a new piece by @LauraKeohane out in JGIM: https://t.co/cz4eTvQPyp https://t.co/DI23tQvp7s
New study worth reading: out-of-pocket costs have increased for #MedicareAdvantage enrollees who take cancer drugs covered under Part B.. This is not something people tend to consider when choosing a plan, unless they are already in treatment. https://t.co
RT @LauraKeohane: New work out in JGIM for those thinking about #drugprices today: 9 in 10 Medicare Advantage enrollees have 20% coinsuranc…
RT @LauraKeohane: New work out in JGIM for those thinking about #drugprices today: 9 in 10 Medicare Advantage enrollees have 20% coinsuranc…
RT @JournalGIM: Cost-Sharing for Part B Chemotherapy Drugs in Medicare Advantage Plans: an Administrative Data Analysis https://t.co/GwaQTu…
RT @LauraKeohane: New work out in JGIM for those thinking about #drugprices today: 9 in 10 Medicare Advantage enrollees have 20% coinsuranc…
RT @LauraKeohane: New work out in JGIM for those thinking about #drugprices today: 9 in 10 Medicare Advantage enrollees have 20% coinsuranc…
RT @LauraKeohane: New work out in JGIM for those thinking about #drugprices today: 9 in 10 Medicare Advantage enrollees have 20% coinsuranc…
New work out in JGIM for those thinking about #drugprices today: 9 in 10 Medicare Advantage enrollees have 20% coinsurance for Part B chemotherapy drugs administered in an outpatient or clinic https://t.co/i3a8aYHgZd /1 https://t.co/g2Iekxkjmm
Cost-Sharing for Part B Chemotherapy Drugs in Medicare Advantage Plans: an Administrative Data Analysis https://t.co/GwaQTuSzzJ